glp-1 pills vs injection Pills: How Do They Compare to Injections? Oral vs. injectable GLP-1s explained

We examine the history of attempts to develop oral GLP-1 therapies, the structural biology of non-peptide GLP-1 receptor activation, the pharmacokinetic advantages of orforglipron's small-molecule architecture, the complete Phase 2 and Phase 3 clinical dataset, comparisons with both oral and injectable GLP-1 agonists, the manufacturing and cost implications of small-molecule production, the safety profile across all completed trials, and the regulatory pathway and timeline for approval

As the popularity of GLP-1 receptor agonists such as Ozempic, Wegovy, and Zepbound increases, a newly reported complication known as Ozempic feet has become a growing concern

[DOI] [PMC free article] [PubMed] [Google Scholar] 78

Arch Endocrinol Metab 66(6):908918 Suarez-Roman G, Fernandez-Romero T, Perera-Calderin AJ, Rodriguez-Sosa VM, Arranz C, Hernandez SC (2016) Pregestational obesity-induced embryopathy

Exenatide became the first FDA-approved GLP-1 analog in 2005